{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T16:49:41Z","timestamp":1792687781914,"version":"4.5.0"},"reference-count":36,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2023,5,10]],"date-time":"2023-05-10T00:00:00Z","timestamp":1683676800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2023,5,10]],"date-time":"2023-05-10T00:00:00Z","timestamp":1683676800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Support Care Cancer"],"published-print":{"date-parts":[[2023,6]]},"DOI":"10.1007\/s00520-023-07791-7","type":"journal-article","created":{"date-parts":[[2023,5,11]],"date-time":"2023-05-11T05:27:06Z","timestamp":1683782826000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Tamoxifen or aromatase inhibitors: which one is the culprit of urinary incontinence in premenopausal breast cancer patients receiving adjuvant hormone therapy?"],"prefix":"10.1007","volume":"31","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-1783-8075","authenticated-orcid":false,"given":"Kubilay","family":"Karaboyun","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5885-3047","authenticated-orcid":false,"given":"Eyyup","family":"Cavdar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7411-1705","authenticated-orcid":false,"given":"Yakup","family":"Ir\u0131agac","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6922-1018","authenticated-orcid":false,"given":"Abdussamet","family":"Celeb\u0131","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9381-1934","authenticated-orcid":false,"given":"Tanju","family":"Kapagan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1998-3150","authenticated-orcid":false,"given":"Ilkay","family":"Gulturk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7705-7027","authenticated-orcid":false,"given":"Ozden","family":"Dem\u0131r","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3773-6620","authenticated-orcid":false,"given":"Okan","family":"Avc\u0131","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9081-2405","authenticated-orcid":false,"given":"Erdogan Selcuk","family":"Seber","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,5,10]]},"reference":[{"issue":"1","key":"7791_CR1","doi-asserted-by":"publisher","first-page":"7","DOI":"10.3322\/caac.21654","volume":"71","author":"RL Siegel","year":"2021","unstructured":"Siegel RL et al (2021) Cancer Statistics, 2021. CA Cancer J Clin 71(1):7\u201333. https:\/\/doi.org\/10.3322\/caac.21654","journal-title":"CA Cancer J Clin"},{"key":"7791_CR2","unstructured":"National Cancer Institute. Cancer stat facts: female breast cancer.\u00a0https:\/\/seer.cancer.gov\/statfacts\/html\/breast.html. Accessed May 16, 2021."},{"key":"7791_CR3","doi-asserted-by":"publisher","unstructured":"(2008) Stat bite: Cancer survivors in the United States. J Natl Cancer Inst 100(4):236. https:\/\/doi.org\/10.1093\/jnci\/djn018","DOI":"10.1093\/jnci\/djn018"},{"issue":"22","key":"7791_CR4","doi-asserted-by":"publisher","first-page":"4945","DOI":"10.1200\/JCO.2005.03.475","volume":"23","author":"V Arndt","year":"2005","unstructured":"Arndt V, Merx H, Stegmaier C, Ziegler H, Brenner H (2005) Persistence of restrictions in quality of life from the first to the third year after diagnosis in women with breast cancer. J Clin Oncol 23(22):4945\u20134953. https:\/\/doi.org\/10.1200\/JCO.2005.03.475","journal-title":"J Clin Oncol"},{"issue":"3","key":"7791_CR5","first-page":"322","volume":"5","author":"E Cavdar","year":"2021","unstructured":"Cavdar E, Iriagac Y, Karaboyun K, Avci O, Seber E (2021) Understanding breast cancer from the patients\u2019 perspective. EJMI 5(3):322\u2013328","journal-title":"EJMI"},{"issue":"7","key":"7791_CR6","doi-asserted-by":"publisher","first-page":"527","DOI":"10.1093\/jnci\/86.7.527","volume":"86","author":"B Fisher","year":"1994","unstructured":"Fisher B et al (1994) Endometrial cancer in tamoxifen-treated breast cancer patients: findings from the National Surgical Adjuvant Breast and Bowel Project (NSABP) B-14. J Natl Cancer Inst 86(7):527\u2013537. https:\/\/doi.org\/10.1093\/jnci\/86.7.527","journal-title":"J Natl Cancer Inst"},{"issue":"4","key":"7791_CR7","doi-asserted-by":"publisher","first-page":"1230","DOI":"10.1016\/j.ajog.2004.12.083","volume":"192","author":"E Chalas","year":"2005","unstructured":"Chalas E, Costantino JP, Wickerham DL et al (2005) Benign gynecologic conditions among participants in the Breast Cancer Prevention Trial. Am J Obstet Gynecol 192(4):1230\u20131239. https:\/\/doi.org\/10.1016\/j.ajog.2004.12.083","journal-title":"Am J Obstet Gynecol"},{"issue":"1-3","key":"7791_CR8","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1016\/s0378-4274(01)00503-3","volume":"127","author":"P Diel","year":"2002","unstructured":"Diel P (2002) Tissue-specific estrogenic response and molecular mechanisms. Toxicol Lett 127(1-3):217\u2013224. https:\/\/doi.org\/10.1016\/s0378-4274(01)00503-3","journal-title":"Toxicol Lett"},{"issue":"2","key":"7791_CR9","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1023\/a:1006263818115","volume":"55","author":"LJ Fallowfield","year":"1999","unstructured":"Fallowfield LJ et al (1999) Assessment of quality of life in women undergoing hormonal therapy for breast cancer: validation of an endocrine symptom subscale for the FACT-B. Breast Cancer Res Treat 55(2):189\u2013199. https:\/\/doi.org\/10.1023\/a:1006263818115","journal-title":"Breast Cancer Res Treat"},{"issue":"6","key":"7791_CR10","doi-asserted-by":"publisher","first-page":"1833","DOI":"10.1007\/s00432-020-03472-8","volume":"147","author":"M Schmidt","year":"2021","unstructured":"Schmidt M et al (2021) Tumor suppression, dose-limiting toxicity and wellbeing with the fetal estrogen estetrol in patients with advanced breast cancer. J Cancer Res Clin Oncol 147(6):1833\u20131842. https:\/\/doi.org\/10.1007\/s00432-020-03472-8","journal-title":"J Cancer Res Clin Oncol"},{"issue":"10","key":"7791_CR11","doi-asserted-by":"publisher","first-page":"3799","DOI":"10.1007\/s00520-019-04671-x","volume":"27","author":"R Stahlschmidt","year":"2019","unstructured":"Stahlschmidt R et al (2019) Adherence and quality of life in women with breast cancer being treated with oral hormone therapy. Support Care Cancer 27(10):3799\u20133804. https:\/\/doi.org\/10.1007\/s00520-019-04671-x","journal-title":"Support Care Cancer"},{"issue":"2","key":"7791_CR12","doi-asserted-by":"publisher","first-page":"529","DOI":"10.1007\/s10549-010-1132-4","volume":"126","author":"DL Hershman","year":"2011","unstructured":"Hershman DL et al (2011) Early discontinuation and non-adherence to adjuvant hormonal therapy are associated with increased mortality in women with breast cancer. Breast Cancer Res Treat 126(2):529\u2013537. https:\/\/doi.org\/10.1007\/s10549-010-1132-4","journal-title":"Breast Cancer Res Treat"},{"issue":"1","key":"7791_CR13","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1159\/000500318","volume":"15","author":"T Sella","year":"2020","unstructured":"Sella T, Chodick G (2020) Adherence and persistence to adjuvant hormonal therapy in early-stage breast cancer patients: a population-based retrospective cohort study in Israel. Breast Care (Basel, Switzerland) 15(1):45\u201353. https:\/\/doi.org\/10.1159\/000500318","journal-title":"Breast Care (Basel, Switzerland)"},{"issue":"2","key":"7791_CR14","doi-asserted-by":"publisher","first-page":"681","DOI":"10.1007\/s10549-011-1703-z","volume":"130","author":"L Nekhlyudov","year":"2011","unstructured":"Nekhlyudov L et al (2011) Five-year patterns of adjuvant hormonal therapy use, persistence, and adherence among insured women with early-stage breast cancer. Breast Cancer Res Treat 130(2):681\u2013689. https:\/\/doi.org\/10.1007\/s10549-011-1703-z","journal-title":"Breast Cancer Res Treat"},{"issue":"11","key":"7791_CR15","doi-asserted-by":"publisher","first-page":"3115","DOI":"10.1007\/s00520-015-2685-x","volume":"23","author":"C Cahir","year":"2015","unstructured":"Cahir C et al (2015) Women\u2019s experiences of hormonal therapy for breast cancer: exploring influences on medication-taking behaviour. Support Care Cancer 23(11):3115\u20133130. https:\/\/doi.org\/10.1007\/s00520-015-2685-x","journal-title":"Support Care Cancer"},{"issue":"1","key":"7791_CR16","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1067\/mob.2003.374","volume":"189","author":"MD Vardy","year":"2003","unstructured":"Vardy MD et al (2003) Short-term urogenital effects of raloxifene, tamoxifen, and estrogen. Am J Obstet Gynecol 189(1):81\u201388. https:\/\/doi.org\/10.1067\/mob.2003.374","journal-title":"Am J Obstet Gynecol"},{"issue":"4 Pt 2","key":"7791_CR17","doi-asserted-by":"publisher","first-page":"722","DOI":"10.1016\/s0029-7844(98)00175-6","volume":"92","author":"L Cardozo","year":"1998","unstructured":"Cardozo L et al (1998) Meta-analysis of estrogen therapy in the management of urogenital atrophy in postmenopausal women: second report of the Hormones and Urogenital Therapy Committee. Obstet Gynecol 92(4 Pt 2):722\u2013727. https:\/\/doi.org\/10.1016\/s0029-7844(98)00175-6","journal-title":"Obstet Gynecol"},{"issue":"34","key":"7791_CR18","doi-asserted-by":"publisher","first-page":"e6785","DOI":"10.1097\/MD.0000000000006785","volume":"96","author":"E Hasanov","year":"2017","unstructured":"Hasanov E, Hasanov M, Kuria IM, Hasanov R, Rzazade R, Jonasch E, Altundag K (2017 Aug) Effects of tamoxifen on urinary incontinence: case report and review of literature. Medicine (Baltimore) 96(34):e6785. https:\/\/doi.org\/10.1097\/MD.0000000000006785","journal-title":"Medicine (Baltimore)"},{"issue":"12","key":"7791_CR19","doi-asserted-by":"publisher","first-page":"1360","DOI":"10.1097\/GME.0000000000000926","volume":"24","author":"ED Cook","year":"2017","unstructured":"Cook ED et al (2017) Missing documentation in breast cancer survivors: genitourinary syndrome of menopause. Menopause 24(12):1360\u20131364. https:\/\/doi.org\/10.1097\/GME.0000000000000926","journal-title":"Menopause"},{"issue":"4","key":"7791_CR20","doi-asserted-by":"publisher","first-page":"1294","DOI":"10.1002\/nau.23470","volume":"37","author":"T Eriguchi","year":"2018","unstructured":"Eriguchi T et al (2018) High luteinizing hormone weakens urinary continence mechanisms in association with prostaglandin E2 elevation in a postmenopausal rat model. Neurourol Urodyn 37(4):1294\u20131301. https:\/\/doi.org\/10.1002\/nau.23470","journal-title":"Neurourol Urodyn"},{"key":"7791_CR21","doi-asserted-by":"crossref","unstructured":"Droupy S, Colson MH, Pello\u2010Leprince\u2010Ringuet N, Perrot V, Descazeaud A. EQUINOXE study: Impact of relational cohesion and sexuality on the quality of life of patients treated with gonadotropin\u2010releasing hormone agonist for prostate cancer. BJUI Compass 2022;3(1):45-54.","DOI":"10.1002\/bco2.92"},{"key":"7791_CR22","doi-asserted-by":"publisher","first-page":"322","DOI":"10.1002\/nau.20041","volume":"23","author":"K Avery","year":"2004","unstructured":"Avery K, Donovan J, Peters TJ et al (2004) ICIQ: A brief and robust measure for evaluating the symptoms and impact of urinary incontinence. Neurourol Urodyn 23:322\u2013330","journal-title":"Neurourol Urodyn"},{"issue":"35","key":"7791_CR23","doi-asserted-by":"publisher","first-page":"4071","DOI":"10.1200\/JCO.21.02844","volume":"40","author":"A Johansson","year":"2022","unstructured":"Johansson A et al (2022) Twenty-year benefit from adjuvant goserelin and tamoxifen in premenopausal patients with breast cancer in a controlled randomized clinical trial. J Clin Oncol 40(35):4071\u20134082. https:\/\/doi.org\/10.1200\/JCO.21.02844","journal-title":"J Clin Oncol"},{"key":"7791_CR24","doi-asserted-by":"publisher","unstructured":"Gremke N et al (2022) Persistence with tamoxifen and aromatase inhibitors in Germany: a retrospective cohort study with 284,383 patients. J Cancer Res Clin Oncol. https:\/\/doi.org\/10.1007\/s00432-022-04376-5","DOI":"10.1007\/s00432-022-04376-5"},{"issue":"2","key":"7791_CR25","doi-asserted-by":"publisher","first-page":"122","DOI":"10.1056\/NEJMoa1803164","volume":"379","author":"PA Francis","year":"2018","unstructured":"Francis PA et al (2018) Tailoring adjuvant endocrine therapy for premenopausal breast cancer. N Engl J Med 379(2):122\u2013137. https:\/\/doi.org\/10.1056\/NEJMoa1803164","journal-title":"N Engl J Med"},{"key":"7791_CR26","doi-asserted-by":"publisher","unstructured":"Chung CP et al (2020) Serial assessment of urinary incontinence in breast cancer survivors undergoing (neo)adjuvant therapy. Journal of the National Comprehensive Cancer Network : JNCCN 18(6):712\u2013716. https:\/\/doi.org\/10.6004\/jnccn.2020.7535","DOI":"10.6004\/jnccn.2020.7535"},{"key":"7791_CR27","first-page":"8","volume":"11","author":"GI Imamoglu","year":"2019","unstructured":"Imamoglu GI et al (2019) Is tamoxifen use a factor affecting continence in breast cancer patients? Cureus 11:8","journal-title":"Cureus"},{"issue":"11","key":"7791_CR28","doi-asserted-by":"publisher","first-page":"726","DOI":"10.1055\/s-0040-1718440","volume":"42","author":"R Stahlschmidt","year":"2020","unstructured":"Stahlschmidt R et al (2020) Urinary incontinence and overactive bladder symptoms in women with breast cancer being treated with oral hormone therapy. Revista Brasileira de Ginecologia e Obstetricia 42(11):726\u2013730. https:\/\/doi.org\/10.1055\/s-0040-1718440","journal-title":"Revista Brasileira de Ginecologia e Obstetricia"},{"key":"7791_CR29","doi-asserted-by":"publisher","unstructured":"Kuiper GG, et al (1997) Comparison of the ligand binding specificity and transcript tissue distribution of estrogen receptors alpha and beta. Endocrinology. 138(3):863\u201370. https:\/\/doi.org\/10.1210\/endo.138.3.4979\u00a0","DOI":"10.1210\/endo.138.3.4979"},{"issue":"3","key":"7791_CR30","doi-asserted-by":"publisher","first-page":"244","DOI":"10.1593\/tlo.13247","volume":"6","author":"SK George","year":"2013","unstructured":"George SK, Tovar-Sepulveda V, Shen SS, Jian W, Zhang Y, Hilsenbeck SG et al (2013) Chemoprevention of BBN-induced bladder carcinogenesis by the selective estrogen receptor modulator tamoxifen. Transl Oncol 6(3):244\u2013255","journal-title":"Transl Oncol"},{"issue":"1","key":"7791_CR31","doi-asserted-by":"publisher","first-page":"386","DOI":"10.1016\/j.juro.2009.08.107","volume":"183","author":"ST Tanaka","year":"2010","unstructured":"Tanaka ST, Ishii K, Demarco RT, Pope JC, Brock JW, Hayward SW (2010) Endodermal origin of bladder trigone inferred from mesenchymal-epithelial interaction. J Urol 183(1):386\u2013391","journal-title":"J Urol"},{"issue":"5","key":"7791_CR32","doi-asserted-by":"publisher","first-page":"1523","DOI":"10.1016\/j.ajog.2004.11.042","volume":"192","author":"AL Clark","year":"2005","unstructured":"Clark AL, Slayden OD, Hettrich K, Brenner RM (2005) \u00d6strojen, rhesus makak\u0131n\u0131n pelvik destek dokular\u0131nda kollajen I ve III mRNA ekspresyonunu artt\u0131r\u0131r. Ben. J Obstet Gynecol 192(5):1523\u20131529. https:\/\/doi.org\/10.1016\/j.ajog.2004.11.042","journal-title":"J Obstet Gynecol"},{"issue":"3","key":"7791_CR33","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1046\/j.1471-0528.2003.02327.x","volume":"110","author":"YS Hannestad","year":"2003","unstructured":"Hannestad YS et al (2003) Are smoking and other lifestyle factors associated with female urinary incontinence? The Norwegian EPINCONT Study. BJOG 110(3):247\u2013254","journal-title":"BJOG"},{"issue":"2","key":"7791_CR34","doi-asserted-by":"publisher","first-page":"339","DOI":"10.1016\/j.ajog.2005.07.051)","volume":"194","author":"KN Danforth","year":"2006","unstructured":"Danforth KN et al (2006) Risk factors for urinary incontinence among middle-aged women. Am J Obstet Gynecol 194(2):339\u2013345. https:\/\/doi.org\/10.1016\/j.ajog.2005.07.051)","journal-title":"Am J Obstet Gynecol"},{"issue":"5","key":"7791_CR35","first-page":"469","volume":"66","author":"P Padmanabhan","year":"2014","unstructured":"Padmanabhan P, Dmochowski R (2014) Urinary incontinence in women: a comprehensive review of the pathophysiology, diagnosis and treatment. Minerva Ginecol 66(5):469\u2013478","journal-title":"Minerva Ginecol"},{"issue":"35","key":"7791_CR36","doi-asserted-by":"publisher","first-page":"3948","DOI":"10.1200\/JCO.2014.55.6993","volume":"32","author":"AJ Tevaarwerk","year":"2014","unstructured":"Tevaarwerk AJ et al (2014) Phase III comparison of tamoxifen versus tamoxifen plus ovarian function suppression in premenopausal women with node-negative, hormone receptor-positive breast cancer (E-3193, INT-0142): a trial of the Eastern Cooperative Oncology Group. J Clin Oncol 32(35):3948\u20133958. https:\/\/doi.org\/10.1200\/JCO.2014.55.6993","journal-title":"J Clin Oncol"}],"container-title":["Supportive Care in Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00520-023-07791-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00520-023-07791-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00520-023-07791-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,6,10]],"date-time":"2023-06-10T09:07:42Z","timestamp":1686388062000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00520-023-07791-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,5,10]]},"references-count":36,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2023,6]]}},"alternative-id":["7791"],"URL":"https:\/\/doi.org\/10.1007\/s00520-023-07791-7","relation":{},"ISSN":["0941-4355","1433-7339"],"issn-type":[{"value":"0941-4355","type":"print"},{"value":"1433-7339","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,5,10]]},"assertion":[{"value":"10 November 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 May 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 May 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The present study was performed in line with the principles of the Declaration of Helsinki. The Tekirdag Namik Kemal University Ethics Committee granted formal approval to this study (approval no: 2021.138.05.11 on May 27th, 2021).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"Informed consent was obtained from all individual participants included in the study.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate"}},{"value":"Not applicable.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}],"article-number":"330"}}